Cohen Amir 4
4 · Strata Critical Medical, Inc. · Filed May 13, 2026
Research Summary
AI-generated summary of this filing
Strata Critical Medical (SRTA) Chief Accounting Officer Amir Cohen Sells 14,306 Shares
What Happened
Amir Cohen, Chief Accounting Officer of Strata Critical Medical (SRTA), reported the sale of 14,306 shares on May 11, 2026. The shares were disposed for a total reported value of approximately $82,832 at a weighted average price of $5.79 per share (individual trades ranged $5.79–$5.81). This was a sale (S), not a purchase.
Key Details
- Transaction date: May 11, 2026; Form 4 filed May 13, 2026 (filed within the typical two-business-day window).
- Price: Weighted average $5.79; trades ranged $5.79–$5.81 (report notes multiple transactions; details available on request).
- Shares sold: 14,306; total proceeds ≈ $82,832.
- Shares owned after transaction: Not specified in the provided filing excerpt.
- Footnotes: Transaction executed pursuant to a Rule 10b5‑1 trading plan adopted December 10, 2025 (preplanned trading). The filer offers to provide breakdown of shares sold at each separate price within the reported range upon request.
Context
Sales executed under a 10b5‑1 plan are preauthorized and commonly used to avoid timing questions; they are routine and do not, by themselves, indicate insider sentiment about the company's prospects. This report documents a disposition (sale), which retail investors should interpret as a routine insider sale unless additional context suggests otherwise.
Insider Transaction Report
- Sale
Class A common stock, $0.0001 par value per share
[F1][F2]2026-05-11$5.79/sh−14,306$82,832→ 202,138 total
Footnotes (2)
- [F1]This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2025.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.79 to $5.81, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.